These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21293921)

  • 41. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):516-25. PubMed ID: 17405996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress.
    Kim HA; Ahn SH; Nam SJ; Park S; Ro J; Im SA; Jung YS; Yoon JH; Hur MH; Choi YJ; Lee SJ; Jeong J; Cho SH; Kim SY; Lee MH; Kim LS; Moon BI; Kim TH; Park C; Kim SJ; Jung SH; Park H; Gwak GH; Kang SH; Kim JG; Kim J; Choi SY; Lim CW; Kim D; Yoo Y; Song YJ; Kang YJ; Jung SS; Shin HJ; Lee KJ; Han SH; Lee ES; Han W; Kim HJ; Noh WC
    BMC Cancer; 2016 May; 16():319. PubMed ID: 27197523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.
    Suh KJ; Kim SH; Lee KH; Kim TY; Kim YJ; Han SW; Kang E; Kim EK; Kim K; No JH; Han W; Noh DY; Lee M; Kim HS; Im SA; Kim JH
    Cancer Res Treat; 2017 Oct; 49(4):1153-1163. PubMed ID: 28253566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
    ; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD
    J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
    Tripathy D; Im SA; Colleoni M; Franke F; Bardia A; Harbeck N; Hurvitz SA; Chow L; Sohn J; Lee KS; Campos-Gomez S; Villanueva Vazquez R; Jung KH; Babu KG; Wheatley-Price P; De Laurentiis M; Im YH; Kuemmel S; El-Saghir N; Liu MC; Carlson G; Hughes G; Diaz-Padilla I; Germa C; Hirawat S; Lu YS
    Lancet Oncol; 2018 Jul; 19(7):904-915. PubMed ID: 29804902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients.
    Jäger W; Sauerbrei W
    Breast Cancer Res Treat; 1995 Jun; 34(3):279-87. PubMed ID: 7579492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
    Fisher B; Jeong JH; Anderson S; Wolmark N
    J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Hrushesky WJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1720-1. PubMed ID: 12441329
    [No Abstract]   [Full Text] [Related]  

  • 49. The Effect of Menstrual Cycle Phase on the Prognostic Factors in Patients with Premenopausal Breast Tumors.
    Kundaktepe BP; Durmus S; Papila C; Velidedeoglu M; Gelisgen R; Uzun H
    Chirurgia (Bucur); 2021; 116(2):209-213. PubMed ID: 33950817
    [No Abstract]   [Full Text] [Related]  

  • 50. Premenopausal gynecologic surgery and survival among black and white women with breast cancer.
    Roberson ML; Nichols HB; Olshan AF; A Troester M; Robinson WR
    Cancer Causes Control; 2020 Feb; 31(2):105-112. PubMed ID: 31828465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.
    Kimball A; Dichtel LE; Nyer MB; Mischoulon D; Fisher LB; Cusin C; Dording CM; Trinh NH; Yeung A; Haines MS; Sung JC; Pinna G; Rasmusson AM; Carpenter LL; Fava M; Klibanski A; Miller KK
    Psychoneuroendocrinology; 2020 Feb; 112():104512. PubMed ID: 31780185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in measured mammographic density in the menstrual cycle.
    Hovhannisyan G; Chow L; Schlosser A; Yaffe MJ; Boyd NF; Martin LJ
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1993-9. PubMed ID: 19567508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
    ; Castiglione-Gertsch M; O'Neill A; Price KN; Goldhirsch A; Coates AS; Colleoni M; Nasi ML; Bonetti M; Gelber RD
    J Natl Cancer Inst; 2003 Dec; 95(24):1833-46. PubMed ID: 14679153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival.
    Senie RT; Rosen PP; Rhodes P; Lesser ML
    Ann Intern Med; 1991 Sep; 115(5):337-42. PubMed ID: 1863022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
    Colleoni M; Bonetti M; Coates AS; Castiglione-Gertsch M; Gelber RD; Price K; Rudenstam CM; Lindtner J; Collins J; Thürlimann B; Holmberg S; Veronesi A; Marini G; Goldhirsch A
    J Clin Oncol; 2000 Feb; 18(3):584-90. PubMed ID: 10653873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is it time to develop an optimal endocrine therapy for premenopausal patients with axillary node positive and negative breast cancer?
    Bilimoria MM; Jordan VC
    Semin Surg Oncol; 1996; 12(5):339-45. PubMed ID: 8873322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Menstrual bleeding, cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled analysis of three cohorts.
    Najmabadi S; Schliep KC; Simonsen SE; Porucznik CA; Egger MJ; Stanford JB
    Paediatr Perinat Epidemiol; 2020 May; 34(3):318-327. PubMed ID: 32104920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
    Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
    Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).
    Bramwell VHC; Pritchard KI; Tu D; Tonkin K; Vachhrajani H; Vandenberg TA; Robert J; Arnold A; O'Reilly SE; Graham B; Shepherd L
    Ann Oncol; 2010 Feb; 21(2):283-290. PubMed ID: 19628570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical oophorectomy for breast cancer: back to the future.
    Love RR; Uy GB
    Future Oncol; 2008 Dec; 4(6):785-92. PubMed ID: 19086845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.